XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.10.0.1

RELATED-PARTY TRANSACTIONS | 9 Months Ended
--- | ---
Jun. 29, 2018
Related Party Transactions [Abstract] |
RELATED-PARTY TRANSACTIONS | RELATED-PARTY TRANSACTIONS Transactions with Varian Medical Systems, Inc. During the three months ended June 29, 2018 and June 30, 2017, the Company recorded sales to Varian of $6.9 million and $6.4 million, respectively, and recorded purchases of products from Varian of $1.0 million and $0.5 million, respectively. During the nine months ended June 29, 2018 and June 30, 2017, the Company recorded sales to Varian of $12.8 million and $19.2 million, respectively, and recorded purchases of products from Varian of $2.5 million and $1.4 million, respectively. Allocated Costs Prior to the separation and distribution on January 28, 2017, the condensed consolidated financial statements included allocations of corporate expenses from Varian to the Company. These allocated expenses included costs of information technology, human resources, accounting, legal, facilities, insurance, treasury and other corporate and infrastructure services. These costs were allocated to the Company on the basis of direct usage when identifiable or other systematic measures that reflect utilization of services provided to or benefits received by the Company. Allocated costs included in the accompanying condensed consolidated statements of earnings are as follows:
| Three Months Ended |  | Nine Months Ended
(In millions) | June 29, 2018 |  | June 30, 2017 |  | June 29, 2018 |  | June 30, 2017
Selling, general and administrative | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 12.4 |
Interest expense, net of interest income | — |  |  | — |  |  | — |  |  | 0.5 |
Equity Method Investment The Company has a 40% ownership interest in dpiX Holding LLC (“dpiX Holding”), a four-member consortium that has a 100% ownership interest in dpiX LLC (“dpiX”), a supplier of amorphous silicon based thin film transistor arrays for digital flat panel image detectors. In accordance with the dpiX Holding operating agreement, net profits or losses are allocated to the members, in accordance with their ownership interests. The equity investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated. During the three months ended June 29, 2018 and June 30, 2017, the Company recorded income on the equity investment in dpiX Holding of $0.9 million and $2.3 million, respectively. During the nine months ended June 29, 2018 and June 30, 2017, the Company recorded income on the equity investment in dpiX Holding of $3.9 million and $2.9 million, respectively. Income and loss on the equity investment in dpiX Holding is included in other income (expense), net in the condensed consolidated statements of earnings. The carrying value of the equity investment in dpiX Holding was $49.6 million and $50.0 million at June 29, 2018 and September 29, 2017, respectively, and comprises the majority of the Company's investments in privately-held companies on the condensed consolidated balance sheets of $52.6 million and $52.3 million at June 29, 2018 and September 29, 2017, respectively. During the three months ended June 29, 2018 and June 30, 2017, the Company purchased glass transistor arrays from dpiX totaling $5.6 million and $5.3 million, respectively. During the nine months ended June 29, 2018 and June 30, 2017, the Company purchased glass transistor arrays from dpiX totaling $17.6 million and $10.9 million, respectively. These purchases of glass transistor arrays are included as a component of inventories on the condensed consolidated balance sheets or cost of revenues—product in the condensed consolidated statements of earnings for these fiscal years. As of June 29, 2018 and September 29, 2017, the Company had accounts payable to dpiX totaling $3.9 million and $3.4 million, respectively. In October 2013, the Company entered into an amended agreement with dpiX and other parties that, among other things, provides the Company with the right to 50% of dpiX’s total manufacturing capacity produced after January 1, 2014. The amended agreement requires the Company to pay for 50% of the fixed costs (as defined in the amended agreement), as determined at the beginning of each calendar year. In January 2018, the fixed cost commitment was determined and approved by the dpiX board of directors to be $16.3 million for calendar year 2018. As of June 29, 2018, the Company had fixed cost commitments of $8.2 million related to this credit agreement remaining for calendar year 2018. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement). The Company has determined that dpiX is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX’s economic performance. The Company does not have majority voting rights and no power to direct the activities of dpiX and therefore is not the primary beneficiary of dpiX. The Company’s exposure to loss as a result of its involvement with dpiX is limited to the carrying value of the Company’s investment and fixed cost commitments.

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -URI http://asc.fasb.org/topic&trid=2122745 + Details
Name: | us-gaap_RelatedPartyTransactionsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration